A Phase 2, Multicenter, Randomized, Parallel-Arm, Placebo-Controlled Study of LY3074828 in Subjects With Active Crohn's Disease (SERENITY)
收藏DataCite Commons2026-03-18 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/PR00012854/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of this study is to evaluate the safety and effectiveness of the study drug Mirikizumab in participants with active Crohn's Disease.
提供机构：
Vivli
创建时间：
2026-03-18
